: Centro de Educación Médica e Investigaciones Clínicas "Norberto Quirno" (CEMIC)
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bonvehi, Pablo
NCT05475704: Effectiveness of Chinese COVID-19 Vaccines in Latin America and the Caribbean

Completed
N/A
59
RoW
P95, Centers for Disease Control and Prevention, China
COVID-19
07/23
07/23
NCT01056185: Respiratory Virus Hospitalization Study (FLU 003 Plus)

Completed
N/A
1000
Europe, US, RoW
University of Minnesota, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Clinical & Translational Science Institute, University of Minnesota
Influenza, Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV), Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
08/24
08/24
Bonhevi, Pablo
NCT05475704: Effectiveness of Chinese COVID-19 Vaccines in Latin America and the Caribbean

Completed
N/A
59
RoW
P95, Centers for Disease Control and Prevention, China
COVID-19
07/23
07/23
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bonvehi, Pablo
NCT05475704: Effectiveness of Chinese COVID-19 Vaccines in Latin America and the Caribbean

Completed
N/A
59
RoW
P95, Centers for Disease Control and Prevention, China
COVID-19
07/23
07/23
NCT01056185: Respiratory Virus Hospitalization Study (FLU 003 Plus)

Completed
N/A
1000
Europe, US, RoW
University of Minnesota, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Clinical & Translational Science Institute, University of Minnesota
Influenza, Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV), Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
08/24
08/24
Bonhevi, Pablo
NCT05475704: Effectiveness of Chinese COVID-19 Vaccines in Latin America and the Caribbean

Completed
N/A
59
RoW
P95, Centers for Disease Control and Prevention, China
COVID-19
07/23
07/23

Download Options